UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009318 |
|---|---|
| Receipt number | R000010945 |
| Scientific Title | A Phase II trial of irinotecan / S-1 (IRIS) + alfa (Panitumumab/Bevacizumab) as 2nd line chemotherapy for metastatic colorectal cancer (mCRC) A multicenter phase II trial of TS1 + Irinotecan (IRIS) + Bevacizumab as second line treatment in patients with KRAS mutant type unresectable advanced colorectal cancer (mCRC). |
| Date of disclosure of the study information | 2012/11/12 |
| Last modified on | 2015/05/12 11:07:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/11/12 16:32:43 | ||
| 2 | Update | 2015/05/12 11:07:04 | Email |
|
| 3 | Update | 2015/05/12 11:07:43 | Recruitment status |
